진매트릭스

본문 바로가기
Search

Newborn Genetic Screening

  • TheraTyper - GJB2

    Detection of GJB2 Mutation Associated with Congenital Hearing Loss in the Newborn

    TheraTyper-GJB2 is an RFMP technology-based GJB2 (connexin26) gene mutation test which enables prenatal prediction and newborn screening of hearing impairment.


Copyright 2018 © Genematrix Inc., All rights reserved.

Copyrights 2018 ⓒ Genematrix. co.ltd., All rights reserved.